Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Vancomycin for Primary Sclerosing Cholangitis
NCT01802073Phase 3Completed
- Sponsor
- Stanford University
- Start
- Jan 2012
- Primary completion
- Aug 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin in Primary Sclerosing Cholangitis (PSC), sponsored by Stanford University. Started Jan 2012; status: completed.
02
Drugs
vancomycin
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT01802073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802073.